Govt approves stepping up of Remdesivir Drug production

Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3500 by the end of this week to fight against COVID.

| April 15, 2021


#Remdesivir   #CovidVaccine   #Corona   #Coronavaccine   #NationalPharmaceuticalPricingAuthority   #DCGI   #Vaccineexport  
The government has reviewed the issue of availability of Remdesivir Drug and has decided to increase the production and decrease the price of the drug. The government has​ also issued a ban on its export. Remdesivir is the first drug approved by the FDA for treating the SARS-CoV-2 virus. 
 
The review was done by Mansukh Mandaviya, Minister of State, For Ports, Shipping and Waterways (Independent Charge) and Chemicals & Fertilizers, Government of India in meetings with the all-existing manufacturers of the Remdesivir drug and other stakeholders on 12th and 13th April 2021.
 
As an additional measure, Remdesivir, API and formulation were placed under the export ban by DGFT to increase the supply of Remdesivir in the domestic market. On Government intervention, Remdesivir supplies of approximately 4 lakh vials meant for export is being diverted by manufacturers to fulfil the domestic requirement. EOU/SEZ units are also being enabled to supply to the domestic market.
 
Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3500 by the end of this week to fight against COVID. Manufactures of Remdesivir have been directed to give priority to fulfil hospital/institutional level supplies. National Pharmaceutical Pricing Authority (NPPA) is continuously monitoring the availability of Remdesivir.
 
Also, DCGI has directed enforcement authorities of states and central government to take immediate action on the incidence of black-marketing, hoarding and overcharging of Remdesivir.
 
The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month. Fast-track approval has been given for seven additional sites having the production capacity of 10 Lakh vials /month to six manufacturers. Another 30 lakh vials/month production is lined up. This would ramp up the production capacity for manufacturing to around 78 lakh vials/month.
 

Comments

 

Other News

‘Better than the entire world’: Here’s the ‘India book’ for ages

The Undying Light: A Personal History of Independent India By Gopalkrishna Gandhi Aleph Books, 624 pages, Rs 999 Vet

Why the youth’s ‘affair’ with stock market is usually tragic

Nine out of 10 individual traders in the equity Futures and Options (F&O) segment have incurred net losses, according to a recent SEBI study. What’s even more striking is that a significant portion of these traders are young individuals – students, early professionals and first-time earners

Why recognizing unpaid work makes sense

Across the globe, unpaid domestic and caregiving work remains an unseen yet essential contributor to economic and social well-being. Women, in particular, dedicate significant hours to household tasks and caregiving, yet this labour remains excluded from Gross Domestic Product (GDP) calculations, leading t

News broadcast needs to reinvent, innovate: Sudhir Chaudhary

Popular news anchor and veteran journalist Sudhir Chaudhary says the news broadcast industry has not reinvented itself in the last 20 years, leading to news consumption gradually shifting to other platforms. Unlike social media influencers with millions of followers, there are no stars in the news industry

How education can transform lives — and society

The Moving of Mountains: The Remarkable Story of The Agastya International Foundation By Adhirath Sethi Penguin Enterprise

What the sharp change in South Asian geopolitics means for India

More than a week after the chief adviser of Bangladesh’s interim government, Muhammad Yunus, created a ripple in South Asia by asking China to expand its economic base in his country as it is “the only guardian of the ocean” for India’s seven landlocked northeastern states, New Delh

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now



Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter